Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 12 Aug 2006):

The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.

Full Abstract

Glutamatergic neurotransmission in the CNS plays a predominant role in learning and memory. While NMDA receptors have been extensively studied, less is known about the involvement of group I metabotropic glutamate receptors in this area. The purpose of the present study was to evaluate the contribution of mGluR1 and mGluR5 to both acquisition and expression of behaviours in contextual and auditory fear conditioning models. The effects of both receptor types were tested using selective antagonists:
(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM) for mGluR1, and [(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) for mGluR5. Their effects on acquisition were compared to those of the NMDA receptor antagonist (+)MK-801, and the unselective muscarinic antagonist scopolamine, while diazepam and citalopram served as reference compounds in the expression experiments. EMQMCM (1.25 to 5mg/kg) impaired acquisition of contextual fear conditioning (CFC), but not auditory fear conditioning (AFC). Similarly, administration of MTEP during the acquisition phase impaired learning in CFC at doses of 2.5 to 10mg/kg, but was ineffective in AFC. When given before the retention test, both EMQMCM (1 and 3mg/kg) and MTEP (3mg/kg) impaired expression of CFC. In contrast, MTEP (2.5 and 5mg/kg) blocked the expression of AFC, while EMQMCM was ineffective. In conclusion, group I mGlu receptors are shown to be involved in the acquisition of hippocampus-dependent CFC, but not hippocampus-independent AFC. Unlike mGluR5, mGluR1 does not seem be involved in expression of AFC.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Gravius, A (A); Barberi, C (C); Schäfer, D (D); Schmidt, W J (WJ); Danysz, W (W);

Affiliation: Preclinical R & D, Merz Pharmaceuticals GmbH, Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, Germany.

Journal and publication information

Publication Type: Journal Article

Journal: Neuropharmacology (Neuropharmacology), published in England. (Language: eng)

Reference: 2006-Dec; vol 51 (issue 7-8) : pp 1146-55

Dates: Created 2006/11/19; Completed 2007/03/09;

PMID: 16905160, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxycyclohexyl)methanone methanesulfonate (0) ; 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine (0) ; Excitatory Amino Acid Agonists (0) ; Excitatory Amino Acid Antagonists (0) ; Pyridines (0) ; Quinolines (0) ; Receptors, Metabotropic Glutamate (0) ; Thiazoles (0) ; metabotropic glutamate receptor 5 (0) ; metabotropic glutamate receptor type 1 (0) ; Diazepam (439-14-5) ; Scopolamine (51-34-3) ; Citalopram (59729-33-8) ; Dizocilpine Maleate (77086-22-7)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

8/30/2004
5/14/2008
Higher Relevance Score (18)
Lower Relevance Score (15)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index